Antimicrobial resistance of Helicobacter pylori: clinical and molecular aspects.

Manuel Valenzuela Valderrama; Héctor Toledo; Oscar Cerda; Cristián Vallejos

doi:10.4067/S0034-98872003001100014

Antimicrobial resistance of Helicobacter pylori: clinical and molecular aspects.

Manuel Valenzuela Valderrama
, Héctor Toledo
, Oscar Cerda
, Cristián Vallejos

Facultad de Medicina de la Universidad de Chile

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the complexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance.

Original language	Undefined/Unknown
Pages (from-to)	1313-1320
Journal	Revista Medica de Chile
Volume	131
Issue number	11
DOIs	https://doi.org/10.4067/S0034-98872003001100014
State	Published - 1 Nov 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.4067/S0034-98872003001100014

Cite this

@article{4f5e981e92c74cf1aa5bd13d423b34c0,

title = "Antimicrobial resistance of Helicobacter pylori: clinical and molecular aspects.",

abstract = "Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the complexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance.",

keywords = "Antibiotics, Drug therapy, Helicobacter pylori",

author = "\{Valenzuela Valderrama\}, Manuel and H{\'e}ctor Toledo and Oscar Cerda and Cristi{\'a}n Vallejos",

year = "2003",

month = nov,

day = "1",

doi = "10.4067/S0034-98872003001100014",

language = "Undefined/Unknown",

volume = "131",

pages = "1313--1320",

journal = "Revista Medica de Chile",

issn = "0034-9887",

number = "11",

}

TY - JOUR

T1 - Antimicrobial resistance of Helicobacter pylori: clinical and molecular aspects.

AU - Valenzuela Valderrama, Manuel

AU - Toledo, Héctor

AU - Cerda, Oscar

AU - Vallejos, Cristián

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the complexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance.

AB - Helicobacter pylori is a relevant pathogen for gastroduodenal diseases in human beings. Although its eradication often improves gastroduodenal diseases, H pylori is acquiring an elevated rate of resistance to various antimicrobials, such as metronidazole, clarithromycin, tetracycline and amoxicillin. Multi-drug resistance is a major problem to select the appropriate treatment of infectious diseases. To improve our understanding on the complexity of the problem, in this article we review the resistance mechanisms and give an update on H pylori antimicrobial resistance.

KW - Antibiotics

KW - Drug therapy

KW - Helicobacter pylori

U2 - 10.4067/S0034-98872003001100014

DO - 10.4067/S0034-98872003001100014

M3 - Article

C2 - 14743695

SN - 0034-9887

VL - 131

SP - 1313

EP - 1320

JO - Revista Medica de Chile

JF - Revista Medica de Chile

IS - 11

ER -